Genetec Technology Bhd
KLSE:GENETEC
Balance Sheet
Balance Sheet Decomposition
Genetec Technology Bhd
Current Assets | 437.3m |
Cash & Short-Term Investments | 163.1m |
Receivables | 259.2m |
Other Current Assets | 15.1m |
Non-Current Assets | 139.5m |
PP&E | 131.8m |
Intangibles | 5.1m |
Other Non-Current Assets | 2.6m |
Current Liabilities | 97.8m |
Accounts Payable | 26.6m |
Short-Term Debt | 34.6m |
Other Current Liabilities | 36.6m |
Non-Current Liabilities | 20.6m |
Long-Term Debt | 10.5m |
Other Non-Current Liabilities | 10.1m |
Balance Sheet
Genetec Technology Bhd
Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
7
|
19
|
9
|
6
|
16
|
14
|
16
|
32
|
31
|
33
|
|
Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
33
|
|
Cash Equivalents |
7
|
19
|
9
|
6
|
16
|
14
|
16
|
32
|
31
|
0
|
|
Short-Term Investments |
0
|
0
|
0
|
6
|
6
|
2
|
5
|
12
|
1
|
147
|
|
Total Receivables |
21
|
49
|
20
|
28
|
27
|
49
|
44
|
24
|
165
|
178
|
|
Accounts Receivables |
20
|
49
|
19
|
27
|
26
|
47
|
44
|
24
|
165
|
167
|
|
Other Receivables |
2
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
11
|
|
Inventory |
14
|
27
|
12
|
7
|
15
|
7
|
12
|
12
|
46
|
17
|
|
Other Current Assets |
5
|
3
|
2
|
0
|
1
|
0
|
0
|
0
|
1
|
4
|
|
Total Current Assets |
47
|
98
|
43
|
47
|
66
|
72
|
77
|
80
|
244
|
379
|
|
PP&E Net |
45
|
42
|
40
|
36
|
36
|
35
|
34
|
36
|
41
|
114
|
|
PP&E Gross |
45
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
114
|
|
Accumulated Depreciation |
13
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
|
Intangible Assets |
0
|
0
|
21
|
16
|
16
|
0
|
0
|
0
|
0
|
0
|
|
Goodwill |
21
|
21
|
0
|
0
|
0
|
11
|
5
|
5
|
5
|
5
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
1
|
0
|
0
|
0
|
2
|
2
|
4
|
4
|
3
|
|
Other Assets |
21
|
21
|
0
|
0
|
0
|
11
|
5
|
5
|
5
|
5
|
|
Total Assets |
113
N/A
|
162
+43%
|
104
-36%
|
98
-5%
|
118
+20%
|
120
+2%
|
119
-1%
|
124
+5%
|
294
+136%
|
501
+70%
|
|
Liabilities | |||||||||||
Accounts Payable |
10
|
48
|
0
|
18
|
18
|
17
|
19
|
20
|
34
|
29
|
|
Accrued Liabilities |
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Short-Term Debt |
11
|
0
|
0
|
3
|
8
|
6
|
5
|
8
|
86
|
44
|
|
Current Portion of Long-Term Debt |
15
|
33
|
5
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
|
Other Current Liabilities |
9
|
5
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
8
|
|
Total Current Liabilities |
47
|
86
|
22
|
23
|
28
|
25
|
27
|
31
|
123
|
85
|
|
Long-Term Debt |
7
|
14
|
13
|
11
|
11
|
10
|
9
|
8
|
9
|
8
|
|
Deferred Income Tax |
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Minority Interest |
1
|
4
|
6
|
6
|
8
|
8
|
7
|
7
|
8
|
9
|
|
Other Liabilities |
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Liabilities |
59
N/A
|
104
+76%
|
41
-60%
|
41
-2%
|
48
+19%
|
44
-9%
|
44
-1%
|
47
+7%
|
142
+203%
|
104
-27%
|
|
Equity | |||||||||||
Common Stock |
35
|
35
|
35
|
54
|
58
|
63
|
63
|
69
|
88
|
266
|
|
Retained Earnings |
1
|
4
|
9
|
4
|
11
|
12
|
12
|
9
|
64
|
132
|
|
Additional Paid In Capital |
18
|
18
|
18
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Equity |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
Total Equity |
54
N/A
|
58
+8%
|
62
+8%
|
58
-7%
|
69
+20%
|
75
+9%
|
75
0%
|
78
+4%
|
153
+96%
|
397
+160%
|
|
Total Liabilities & Equity |
113
N/A
|
162
+43%
|
104
-36%
|
98
-5%
|
118
+20%
|
120
+2%
|
119
-1%
|
124
+5%
|
294
+136%
|
501
+70%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
35
|
35
|
457
|
457
|
513
|
549
|
551
|
593
|
682
|
750
|